[HTML][HTML] Differential serum lipid distribution in IPAH and CHD-PAH patients
J Chen, A Rathinasabapathy, J Luo, X Yang, P Luo… - Respiratory …, 2022 - Elsevier
Lipid homeostasis is dysregulated in pulmonary arterial hypertension (PAH). A decrease in
serum high-and low-density lipoprotein cholesterol (HDL-C and LDL-C) is significantly …
serum high-and low-density lipoprotein cholesterol (HDL-C and LDL-C) is significantly …
Examining the Effectiveness of Monotherapy versus Combination Therapy for Pulmonary Hypertension in Patients with Congenital Heart Disease: A Short-Term …
M Rahman, AZ Basunia, P Das, SK Singha - IJCIC-International Journal of …, 2022 - ijcic.com
Introduction: Pulmonary arterial hypertension (PAH) is a serious condition characterized by
a gradual increase in pulmonary vascular resistance, which can lead to right heart failure …
a gradual increase in pulmonary vascular resistance, which can lead to right heart failure …
[PDF][PDF] Cardiac Tamponade in Eisenmenger Syndrome: A Diagnosing Complexity: Case Report
W Belkho, J SAFI, L Rachid, L Chemaou, Y Malky… - SAS J Med, 2022 - saspublishers.com
Cardiac tamponade is a form of obstructive shock with clinical manifestations consistent with
a low cardiac output and high central venous pressure. Features of a low cardiac output …
a low cardiac output and high central venous pressure. Features of a low cardiac output …